The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Staging investigations for oesophageal cancer: a meta-analysis
Open accessAbstract
The aim of the study was to compare the diagnostic performance of endoscopic ultrasonography (EUS), computed tomography (CT), and 18F-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in staging of oesophageal cancer. PubMed was searched to identify English-language articles published before January 2006 and reporting on diagnostic performance of EUS, CT, and/or FDG-PET in oesophageal cancer patients. Articles were included if absolute numbers of true-positive, false-negative, false-positive, and true-negative test results were available or derivable for regional, celiac, and abdominal lymph node metastases and/or distant metastases. Sensitivities and specificities were pooled using a random effects model. Summary receiver operating characteristic analysis was performed to study potential effects of study and patient characteristics. Random effects pooled sensitivities of EUS, CT, and FDG-PET for regional lymph node metastases were 0.80 (95% confidence interval 0.75-0.84), 0.50 (0.41-0.60), and 0.57 (0.43-0.70), respectively, and specificities were 0.70 (0.65-0.75), 0.83 (0.77-0.89), and 0.85 (0.76-0.95), respectively. Diagnostic performance did not differ significantly across these tests. For detection of celiac lymph node metastases by EUS, sensitivity and specificity were 0.85 (0.72-0.99) and 0.96 (0.92-1.00), respectively. For abdominal lymph node metastases by CT, these values were 0.42 (0.29-0.54) and 0.93 (0.86-1.00), respectively. For distant metastases, sensitivity and specificity were 0.71 (0.62-0.79) and 0.93 (0.89-0.97) for FDG-PET and 0.52 (0.33-0.71) and 0.91 (0.86-0.96) for CT, respectively. Diagnostic performance of FDG-PET for distant metastases was significantly higher than that of CT, which was not significantly affected by study and patient characteristics. The results suggest that EUS, CT, and FDG-PET each play a distinctive role in the detection of metastases in oesophageal cancer patients. For the detection of regional lymph node metastases, EUS is most sensitive, whereas CT and FDG-PET are more specific tests. For the evaluation of distant metastases, FDG-PET has probably a higher sensitivity than CT. Its combined use could however be of clinical value, with FDG-PET detecting possible metastases and CT confirming or excluding their presence and precisely determining the location(s).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2017) · Springer eBooks · doi:10.1007/978-3-319-40618-3 · Cited by 17,242
American Joint Committee on Cancer (2002) · Springer eBooks · doi:10.1007/978-1-4757-3656-4 · Cited by 6,379
Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD Initiative.
Bossuyt, P. M., Reitsma, J. B., Bruns, D. E., Gatsonis, C. A., Glasziou, P. P., Irwig, L. M., Lijmer, J. G., Moher, D., Rennie, D., de Vet, H. C. W., et al. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-1-200301070-00010 · Cited by 3,219
Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative
Bossuyt, P. M., Reitsma, J. B., Bruns, D. E., Gatsonis, C. A., Glasziou, P. P., Irwig, L. M., Lijmer, J. G., Moher, D., Rennie, D., & de Vet, H. C. W. (2003) · BMJ · doi:10.1136/bmj.326.7379.41 · Cited by 3,215
Towards Complete and Accurate Reporting of Studies of Diagnostic Accuracy: The STARD Initiative
Bossuyt, P. M., Reitsma, J. B., Bruns, D. E., Gatsonis, C. A., Glasziou, P. P., Irwig, L. M., Lijmer, J. G., Moher, D., Rennie, D., & de Vet, H. C. W. (2003) · Radiology · doi:10.1148/radiol.2261021292 · Cited by 3,215
(2011) · Hepatogastroenterology · doi:10.5754/hge11155 · Cited by 1,257
Flamen, P., Lerut, A., Van Cutsem, E., De Wever, W., Peeters, M., Stroobants, S., Dupont, P., Bormans, G., Hiele, M., De Leyn, P., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.18.3202 · Cited by 571
Terrin, N., Schmid, C. H., & Lau, J. (2005) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2005.01.006 · Cited by 492
van Westreenen, H. L., Westerterp, M., Bossuyt, P. M. M., Pruim, J., Sloof, G. W., van Lanschot, J. J. B., Groen, H., & Plukker, J. T. M. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.01.083 · Cited by 370
Staging of esophageal cancer with 18F-fluorodeoxyglucose positron emission tomography.
Flanagan, F. L., Dehdashti, F., Siegel, B. A., Trask, D. D., Sundaresan, S. R., Patterson, G. A., & Cooper, J. D. (1997) · American Journal of Roentgenology · doi:10.2214/ajr.168.2.9016218 · Cited by 312
Lerut, T., Flamen, P., Ectors, N., Van Cutsem, E., Peeters, M., Hiele, M., De Wever, W., Coosemans, W., Decker, G., De Leyn, P., et al. (2000) · Annals of Surgery · doi:10.1097/00000658-200012000-00003 · Cited by 267
Improvement in Staging of Esophageal Cancer With the Addition of Positron Emission Tomography
Block, M. I., Patterson, G. A., Sundaresan, R. S., Bailey, M. S., Flanagan, F. L., Dehdashti, F., Siegel, B. A., & Cooper, J. D. (1997) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(97)00619-x · Cited by 259
(1999) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(99)00974-1 · Cited by 235
Räsänen, J. V., Sihvo, E. I. T., Knuuti, J. M., Minn, H. R. I., Luostarinen, M. E., Laippala, P. J., Viljanen, T., & Salo, J. (2003) · Annals of Surgical Oncology · doi:10.1245/aso.2003.12.002 · Cited by 208
Role of Positron Emission Tomography in Staging Esophageal Cancer
Luketich, J. D., Schauer, P. R., Meltzer, C. C., Landreneau, R. J., Urso, G. K., Townsend, D. W., Ferson, P. F., Keenan, R. J., & Belani, C. P. (1997) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(97)00624-3 · Cited by 207
Choi, J. Y., Lee, K. H., Shim, Y. M., Lee, K. S., Kim, J. J., Kim, S. E., & Kim, B. (2000) · PubMed · Cited by 204
Positron emission tomography for staging of oesophageal and gastroesophageal malignancy
Kole, A., Plukker, J., Nieweg, O., & Vaalburg, W. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.526 · Cited by 186
Eloubeidi, M. A., Wallace, M. B., Reed, C. E., Hadzijahic, N., Lewin, D. N., Van Velse, A., Leveen, M. B., Etemad, B., Matsuda, K., Patel, R. S., et al. (2001) · Gastrointestinal Endoscopy · doi:10.1067/mge.2001.119873 · Cited by 176
Rankin, S., Taylor, H., Cook, G., & Mason, R. C. (1998) · Clinical Radiology · doi:10.1016/s0009-9260(98)80292-4 · Cited by 153
van Westreenen, H. L., Heeren, P. A. M., van Dullemen, H. M., van der Jagt, E. J., Jager, P. L., Groen, H., & Plukker, J. T. M. (2004) · Journal of Gastrointestinal Surgery · doi:10.1016/j.gassur.2004.09.055 · Cited by 96
Evaluation of 18F-FDG positron emission tomography in gastric and oesophageal carcinoma.
McAteer, D., Wallis, F., Couper, G. C., Norton, M. Y., Welch, A. E., Bruce, D. M., Park, K., Nicolson, M. C., Gilbert, F. J., & Sharp, P. (1999) · British Journal of Radiology · doi:10.1259/bjr.72.858.10560332 · Cited by 96
Kienle, P., Buhl, K., Kuntz, C., Düx, M., Hartmann, C., Benner, A., Herfarth, C. H., & Lehnert, T. (2002) · Digestion · doi:10.1159/000068360 · Cited by 80
Laparoscopic ultrasonography for staging gastroesophageal cancer
Finch, M. D., John, T. G., Garden, O. J., Allan, P. L., & Paterson‐Brown, S. (1997) · Surgery · doi:10.1016/s0039-6060(97)90176-8 · Cited by 62
Impact of FDG-PET for staging of oesophageal cancer
Imdahl, A., Hentschel, M., Kleimaier, M., Hopt, U., & Brink, I. (2004) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-004-0492-9 · Cited by 39
Cited by
Rustgi, A. K., & El-Serag, H. B. (2014) · New England Journal of Medicine · doi:10.1056/nejmra1314530 · Cited by 1,243
Rice, T. W., Patil, D. T., & Blackstone, E. H. (2017) · Annals of Cardiothoracic Surgery · doi:10.21037/acs.2017.03.14 · Cited by 782
Oesophageal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
Obermannová, R., Alsina, M., Cervantes, A., Leong, T., Lordick, F., Nilsson, M., van Grieken, N. C. T., Vogel, A., & Smyth, E. C. (2022) · Annals of Oncology · doi:10.1016/j.annonc.2022.07.003 · Cited by 730
Recent Advances From Basic and Clinical Studies of Esophageal Squamous Cell Carcinoma
Ohashi, S., Miyamoto, S., Kikuchi, O., Goto, T., Amanuma, Y., & Muto, M. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.08.054 · Cited by 530
Endoscopic submucosal dissection/endoscopic mucosal resection guidelines for esophageal cancer
Ishihara, R., Arima, M., Iizuka, T., Oyama, T., Katada, C., Kato, M., Goda, K., Goto, O., Tanaka, K., Yano, T., et al. (2020) · Digestive Endoscopy · doi:10.1111/den.13654 · Cited by 439
Metadata
- Authors
- van Vliet, E. P. M., Heijenbrok-Kal, M. H., Hunink, M. G. M., Kuipers, E. J., & Siersema, P. D.
- Venue
- British Journal of Cancer
- Published
- 2008-01-22
- Volume
- 98
- Issue
- 3
- Pages
- 547-557
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- OpenAlex
- W1997089403
- Cited by
- 517
- References
- 24
- FWCI
- 4.51
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.